Reviva Pharmaceuticals Holdings, Inc. Preferred Stock, Shares Issued
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Preferred Stock, Shares Issued of 0 shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesIssued · last filed 2026-08-12
- 2026-06-30: Preferred Stock, Shares Issued 0.00 shares.
- 2026-03-31: Preferred Stock, Shares Issued 0.00 shares.
- 2025-12-31: Preferred Stock, Shares Issued 0.00 shares.
- 2025-09-30: Preferred Stock, Shares Issued 0.00 shares.
| Period end | Preferred Stock, Shares Issued |
|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-12 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 0.00 shares 10-Q · filed 2026-08-12 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-15 |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-14 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-04-03 |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-04-15 |
| 2020-11-30 | 0.00 shares 10-Q · filed 2021-01-14 |
| 2020-08-31 | 0.00 shares 10-Q · filed 2020-10-14 |
| 2020-05-31 | 0.00 shares 10-Q · filed 2020-07-07 |
| 2020-02-29 | 0.00 shares 10-Q · filed 2021-01-14 |
| 2019-11-30 | 0.00 shares 10-Q · filed 2020-01-10 |
| 2019-08-31 | 0.00 shares 10-Q · filed 2019-10-08 |
| 2019-05-31 | 0.00 shares 10-Q · filed 2019-07-03 |
| 2019-02-28 | 0.00 shares 10-K · filed 2020-05-04 |
| 2018-11-30 | 0.00 shares 10-Q · filed 2019-01-09 |
| 2018-08-31 | 0.00 shares 10-Q · filed 2018-10-11 |
| 2018-05-31 | 0.00 shares 10-K · filed 2020-05-04 |
| 2018-03-31 | 0.00 shares 10-K · filed 2020-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |